Iranian researchers of Tehran University of Medical Sciences studied and produced a Nano drug system at laboratorial scale to achieve edible insulin.
Author of the study Kobra Omidfar said that the nono-drug increases the diffusivity of insulin to intestinal wall and decreases degradation against enzymes. Biocompatible and non-toxic nanoparticles have been used in the production of the nano-drug, the Iranian students' news agency reported.
The researchers released a covered nanoparticle vesicles synthesized with trimethyl chitosan and investigated its capability for insulin transfer in laboratory.
The results showed that the medical nano-drug prevents insulin destruction and improves permeability of insulin large molecules into monolayer cells of the intestinal wall.
The nano-carrier delays insulin release and boosts its permeability into intestinal wall.